The document profiles the pharmaceutical manufacturing industry in China, finding that the major distribution areas are in Jiangsu, Shandong, and Zhejiang provinces, while secondary distribution areas include Guangdong, Shanghai, Beijing, Hebei, Henan, Liaoning, and Sichuan. It analyzes statistics on industry output, employment, enterprises, revenues, profits, and more for different regions and ownership types. The Zeefer Industry Distribution Index is used to quantitatively assess regional concentration of the pharmaceutical industry across China.

1. Heilongjiang
Jilin
China Pharmaceutical Mfg. Industry Profile
Inner Mongolia
Liaoning
Xinjiang
Beijing
Hebei Tianjin
Shanxi
Ningxia Shandong
China Industry Code: 27
Qinghai
Gansu
Henan Jiangsu
According to the industry distribution index released by Zeefer, the major distribution areas of pharmaceutical mfg.
Shaanxi
industry across China include: Jiangsu, Shandong, Zhejiang, and the second distribution areas include: Guangdong,
Tibet Anhui Shanghai
Shanghai, Beijing, Hebei, Henan, Liaoning and Sichuan.
Hubei
Sichuan Zhejiang
Chongqing
Hunan Jiangxi
Fujian
Guizhou
Yunnan Guangdong
Guangxi
Lesser Distribution Area Beijing Zeefer Consulting Ltd.
Second Distribution Area
Major Distribution Area
Apr. 2011
Hainan

2. Introduction
Through a comparative analysis on the development of pharmaceutical mfg. industry in 31 provincial regions and 20 major cities in visualized form of data
map, the report provides key data and concise analyses on the pharmaceutical mfg. industry in China, a list of top 20 enterprises in the sector as well as
the comparison on investment environment in top 10 hot regions. In addition, the report truly reflects the position of foreign enterprises in pharmaceutical
mfg. industry across China based on a comprehensive comparison of operating conditions among different enterprise types.
This report is based on Chinese industry classification (Industrial Classification For National Economic Activities, GB/T 4754-2002).
Additionally, by original creation of ZEEFER Industry Distribution Index, the report directly shows the difference in various regions of Mainland China in
terms of pharmaceutical mfg. industry, providing an important reference for investors' selection of target regions to make investment.
What will you get from this report?
· To get a comprehensive picture on distribution of and difference in performance in regions of Mainland China in terms of the pharmaceutical mfg.
industry;
· To figure out the hot regions in China for pharmaceutical mfg. industry, find out the potential provinces and cities suitable for investment as well as the
economic development level and investment environment in these regions;
· To get a clear picture on the overall development, industry size and growth trend of pharmaceutical mfg. industry across China in the past 3 years;
· To get a clear picture on development status of foreign enterprises, state-owned enterprises, and private enterprises in recent years as well as the
industry position of the above ownerships;
· Present you with a list of top 20 enterprises inside the industry;
· ……
Regions Covered By This Report
· All the 31 provincial regions in Mainland China;
· Top 20 cities in terms of pharmaceutical mfg. industry.
Enterprise Types Covered By This Report
· Top 20 enterprises;
· Enterprises Funded by Foreign Countries (territories), Hong Kong, Macau and Taiwan;
· Chinese State-owned Enterprises;
· Collective-owned Enterprises;
· Cooperative Enterprises;
· Joint-Equity Enterprises;

3. · Private Enterprises.
ZEEFER Industry Distribution Index
It is an indicator through aggregate weighted computation based on the three authority statistics of enterprise numbers, sales revenue and profit by region
and corporate ownership, and in accordance with the regional distribution of leading enterprises inside the sector. Through horizontal comparison on the
pharmaceutical mfg. industry development in different provinces, municipalities, and autonomous regions, the ZEEFER Industry Distribution Index is
specially designed to truly reflect the conditions of regional distribution for the pharmaceutical mfg. industry, providing a quantitative, visual and reliable
reference for relevant users to make decisions. The ZEEFER Industry Distribution Index adopts a hundred mark system. For a certain region, the higher
the score, the higher the distribution concentration in this region and the industry position of the region shall be more important.
Key Statistic Indicators Covered By This Report
· Industrial Output
· Number Of Employees
· Enterprise Number
· Sales Revenue
· Profits
· Rate Of Return On Sales
· Rate Of Return On Assets
· Rate Of Return On Net Assets
· Number Of Enterprises In Red
· Range Of Loss
· Total Losses
· Percentage Of Foreign-Funded And HK-, Macau-, Taiwan-Funded Enterprises In Terms Of The Sales Revenue
· Percentage Of Foreign-Funded Enterprises In All Foreign-Funded Enterprises And HK-, Macau-, Taiwan-Funded Enterprises In Terms Of The Sales
Revenue
· GDP
· Growth Rate Of GDP
· GDP Per Capita
· Growth Rate Of GDP Per Capita
· Growth Rate Of The Added Value Of Primary Industry
· Growth Rate Of The Added Value Of Secondary Industry
· Growth Rate Of The Added Value Of The Tertiary Industry
· Industrial Value-Added Of Enterprises Above Designated Size
· Growth Rate Of Industrial Value-Added Of Enterprises Above Designated Size
· ......

4. Declaration
Beijing Zeefer Consulting Ltd. and (or) its affiliates (hereafter, "Zeefer") provides this report with the greatest possible
care. Nevertheless, Zeefer makes no guarantee whatsoever regarding the accuracy, utility, or certainty of the
information in this report. Further, Zeefer disclaims any and all responsibility for damages that may result from the use
or non-use of the information in this report.
The information in this report may be incomplete and/or may differ in expression from other information in elsewhere by
other means. The information contained in this report may also be changed or removed without prior notice.

5. Table of Contents
1. Overview
2. The Nationwide Distribution Of Pharmaceutical Mfg. Industry In China
3. Introduction To Major Cities
4. Nationwide Distribution Of Foreign-Funded Enterprises And HK, Macau And Taiwan-Funded Enterprises In Pharmaceutical Mfg. Industry
5. Nationwide Distribution Of Foreign-Funded Enterprises
6. Nationwide Distribution By Enterprise Numbers
7. Sales Revenue Of Foreign-Funded Enterprises And HK, Macau And Taiwan-Funded Enterprises By Region
8. Sales Revenue In Different Regions For Pharmaceutical Mfg. Industry
9. Nationwide Distribution Of Top 100 Enterprises In Terms Of Sales Revenue
10. Comparison Of Foreign-Funded Enterprises And HK, Macau And Taiwan-Funded Enterprises
10.1 Operating Status Of Top 10 Areas With Highest Total Profits
10.2 Comparison On Operating Status Of Foreign-Funded Enterprises And HK, Macau And Taiwan-Funded Enterprises By Region
11. Analysis On Operating Status Of Enterprises By Corporate Ownership
12. Analysis On The Changes In Number Of Enterprises By Corporate Ownership
13. Analysis On The Changes In Sales Revenue By Corporate Ownership
14. Comparison On The Rate Of Return On Assets Of Enterprises
14.1 Comparison On The Rate Of Return On Assets By Corporate Ownership
14.2 Comparison On The Rate Of Return On Assets By Corporate Size
14.3 Comparison On The Rate Of Return On Assets Of Foreign-Funded Enterprises And HK, Macau And Taiwan-Funded Enterprises By Major
Distribution Areas
15. Comparison On The Investment Environment Indexes Of 10 Major Regions
16. List Of Top 20 Enterprises In Terms Of Sales Revenue
17. Index Explanation

6. Sample Report Beijing Zeefer Consulting Ltd.
2. The Nationwide Distribution Of Pharmaceutical Mfg. Industry In China
According to the Zeefer Industry Distribution Indexes, major distribution areas of the pharmaceutical Code Region N Index Points
mfg. industry include Jiangsu, Shandong and Zhejiang. The second distribution areas of the 32 Jiangsu |||||||||||||||||||||||| 98 ||||||||||||||||||||||||
pharmaceutical mfg. industry include Guangdong, Shanghai, Beijing, Hebei, Henan, Liaoning and 37 Shandong |||||||||||||||||||||||| 98 ||||||||||||||||||||||||
Sichuan. 33 Zhejiang ||||||||||||||||||||||| 92 |||||||||||||||||||||||
44 Guangdong |||||||||||||||||||||| 91 ||||||||||||||||||||||
31 Shanghai ||||||||||||||||||| 78 |||||||||||||||||||
11 Beijing |||||||||||||||||| 74 ||||||||||||||||||
23 13 Hebei |||||||||||||||||| 74 ||||||||||||||||||
41 Henan |||||||||||||||||| 74 ||||||||||||||||||
22 21 Liaoning |||||||||||||||||| 73 ||||||||||||||||||
21 51 Sichuan |||||||||||||||||| 73 ||||||||||||||||||
65 15 11 12 Tianjin ||||||||||||||||| 69 |||||||||||||||||
12 22 Jilin |||||||||||||||| 65 ||||||||||||||||
13
64
14
37
42 Hubei ||||||||||||||| 61 |||||||||||||||
63 23 Heilongjiang ||||||||||||||| 60 |||||||||||||||
62 41 32
61 36 Jiangxi |||||||||||||| 59 ||||||||||||||
54 34 31 61 Shaanxi ||||||||||||| 52 |||||||||||||
42
51 33 43 Hunan |||||||||||| 49 ||||||||||||
50
36 35 Fujian |||||||||||| 48 ||||||||||||
43 35
52 34 Anhui ||||||||||| 47 |||||||||||
1-72 15 Inner Mongolia ||||||||| 37 |||||||||
53 45 44
73-91 14 Shanxi |||||||| 35 ||||||||
92+ 53 Yunnan |||||||| 35 ||||||||
46 45 Guangxi |||||||| 33 ||||||||
46 Hainan ||||||| 30 |||||||
ZEEFER Industry Distribution Index: is an indicator through aggregate weighted computation based on 50 Chongqing ||||||| 29 |||||||
the three authority statistics of enterprise numbers, sales revenue and profit by region and corporate 52 Guizhou |||||| 24 ||||||
ownership, and in accordance with the regional distribution of leading enterprises inside the sector. 62 Gansu ||| 13 |||
Through horizontal comparison on the target industry development in different provinces, municipalities 63 Qinghai || 11 ||
and autonomous regions, the ZEEFER Industry Distribution Index is specially designed to truly reflect 64 Ningxia || 11 ||
the conditions of regional distribution for the target industry, providing a quantitative, visual and reliable 65 Xinjiang || 8 ||
reference for relevant users to make decisions. The ZEEFER Industry Distribution Index adopts a 54 Tibet | 6 |
hundred mark system. For a certain region, the higher the score, the higher the distribution concentration
in this region and the industry position of the region shall be more important.
Tel: +86 10 68324716 Fax: +86 10 87750776
Company Site: www.Zeefer.org Online Reports Store: www.AllChinaReports.com 3

7. Sample Report Beijing Zeefer Consulting Ltd.
14.3 Comparison On The Rate Of Return On Assets Of Foreign-Funded Enterprises And HK, Macau And Taiwan-Funded Enterprises By Major Distribution
Areas (2008-2010)
In 2010, the rate of return on assets for foreign-funded enterprises and HK, Macau and Taiwan-funded enterprises was 11.7%, 1.9% higher than
nationwide average. Among foreign-funded enterprises and HK, Macau and Taiwan-funded enterprises in following major distribution areas, those
enterprises in Shandong realized the highest rate of return on assets, and those in Jiangsu, Zhejiang achieved the lowest ROAs. Those foreign-
funded and HK, Macau and Taiwan-funded enterprises in Shandong realized a ROA of 14.2% in 2010, 4.4% higher than the nationwide average,
2.5% higher than that of nationwide average of all foreign-funded and HK, Macau and Taiwan-funded enterprises.
Rate Of Return On Assets % Rate Of Return On Net Assets %
2010 2009 2008 2010 2009 2008 # # # # # #
National Average 9.8 9.1 8.4 18.0 17.2 16.5 # # # # # #
Foreign-Funded All 11.7 11.3 11.0 21.2 20.8 20.7 # # # # # #
And HK, Macau Jiangsu 13.3 13.6 13.6 22.3 23.7 24.3 # # # # # #
And Taiwan-
Funded Shandong 14.2 12.9 15.6 24.5 22.3 28.0 # # # # # #
Enterprises Zhejiang 13.3 13.7 11.9 24.9 26.6 24.2 # # # # # #
# # # # # #
# # # # # #
Rate Of Return On Assets ForForeign-Funded And HK, Rate Of Return On Net Assets For Foreign-Funded And
Macau And Taiwan-Funded Enterprises By Major HK, Macau And Taiwan-Funded Enterprises By Major
Distribution Areas (2008-2010) Distribution Areas (2008-2010)
18.00 30.00
16.00
25.00
14.00
12.00 All 20.00 All
10.00 Jiangsu Jiangsu
15.00
8.00 Shandong Shandong
6.00 Zhejiang 10.00 Zhejiang
4.00
5.00
2.00
0.00 0.00
2008 2009 2010 2008 2009 2010
Tel: +86 10 68324716 Fax: +86 10 87750776
Company Site: www.Zeefer.org Online Reports Store: www.AllChinaReports.com 18

8. Beijing Zeefer Consulting Ltd.
Order Form
Report Name: China Pharmaceutical Mfg. Industry Profile
Report Type: Industry Report
Price, Format and Licence:
□ US$580 for Single User in PDF
□ US$870 for Five Users in PDF
□ US$1450 for Enterprise License in PDF
If you wish to order this report online, please visit the following link. It is simple, safe and faster:
http://www.allchinareports.com/pharmaceuticals-medical-devices/pharmaceutical/china-pharmaceutical-mfg.-
industry-profile-cic27.html
Contact Details:
□Mr □Mrs □Ms Given Name: Family Name:
Email Address:
Job Title: Organization:
Address:
City: Zip Code: Country:
Tel: Fax:
Payment Details:
□ Pay by credit card
□ Visa □ Master Card □ American Express □ JCB
Cardholder's Name:
Card Number:
Expiry Date: CVV Number:
Cardholder's Signature:
Please fax this order form to: +86 10 87750776
If you have any question please contact us at: Email: Service@allchinareports.com Telephone: +86 10 68324716
Tel: +86 10 68324716 Fax: +86 10 87750776
Company Site: www.Zeefer.org Online Reports Store: www.AllChinaReports.com